Cargando…

49. Clinical Utility of Oseltamivir Restriction Policy

BACKGROUND: Inappropriate use of oseltamivir and antibiotics for upper respiratory tract infections may increase risk of microbial resistance. Restriction policies have been used to curtail inappropriate use of oseltamivir and antimicrobials in suspected or confirmed influenza patients. We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kale-Pradhan, Pramodini, Manuel, Martin, Johnson, Leonard B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776335/ http://dx.doi.org/10.1093/ofid/ofaa439.094

Ejemplares similares

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

2008. Outcomes of Patients with Positive Procalcitonin Levels Who Do Not Receive Continued Antibiotics
por: George, Jamie, et al.
Publicado: (2019)

2428. Lower Rates of Antibiotic Treatment of Vancomycin-Resistant Compared With Vancomycin Susceptible Enterococcal Bacteriuria
por: Vendittelli, Bridget, et al.
Publicado: (2018)

1469. Effect of Treatment Duration on Outcomes in Septic Patients Admitted for Urinary Tract Infections from Extended Care Facilities
por: Jongekrijg, Annelise, et al.
Publicado: (2019)

556. Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19
por: Berti, Andrew David, et al.
Publicado: (2020)

1386. Prescribing Patterns of Skin and Soft Tissue Infections in Patients Discharged from the Emergency Department
por: Feist, Jacqueline, et al.
Publicado: (2022)

579. Clinical and Drug Resistance Characteristics of Providencia spp. Infections
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2023)

1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
por: Neuberger, Eddie, et al.
Publicado: (2020)

Oseltamivir dosing with haemofiltration
por: Tomlin, M, et al.
Publicado: (2010)

49. Clinical Characteristics of the 2019 Eastern Equine Encephalitis Virus Outbreak in Michigan
por: Ladzinski, Adam T, et al.
Publicado: (2020)

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022)

Vulnerable COPD patients with comorbidities: the role of roflumilast
por: Lipari, Melissa, et al.
Publicado: (2014)

668. Restricting Ordering of Multiplex Gastrointestinal Panel Improves Test Utilization
por: Tai, Don Bambino Geno, et al.
Publicado: (2021)

2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A
por: Shah, Sunish, et al.
Publicado: (2019)

An in vitro study of elimination of oseltamivir carboxylate by haemofiltration
por: Gruber, P, et al.
Publicado: (2007)

925. Oseltamivir usage in community settings: data from a household transmission study
por: Mellis, Alexandra, et al.
Publicado: (2023)

164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
por: Eljaaly, Khalid, et al.
Publicado: (2021)

Implementation of an Antimicrobial Restriction Policy: Is the “Paper” More Persuasive?
por: Hayes, Lisa, et al.
Publicado: (2017)

49. Impact of a Rapid Genotypic Platform for Gram-negative Bloodstream Infections, Paired with an Antimicrobial Stewardship Intervention, on Time to Optimal Antimicrobial Therapy
por: Donnelly, Madison, et al.
Publicado: (2021)

922. Cost-effectiveness of baloxavir marboxil versus oseltamivir or no treatment for the management of influenza in the United States
por: Hansen, Svenn, et al.
Publicado: (2023)

Adverse drug reactions in drug information databases: does presentation affect interpretation?
por: McConachie, Sean M., et al.
Publicado: (2020)

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION
por: Schlögelhofer, Monika, et al.
Publicado: (2018)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

P49 Determinants of trends in reported antibiotic use for sick children from LMICs (2005–17): analysis of 132 national surveys from 73 countries
por: Allwell-Brown, Gbemisola, et al.
Publicado: (2022)

1715 Oseltamivir use in an Influenza Outbreak: Linking Pharmacology to Pharmacoeconomics
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2014)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Abstracts of the 49th Annual Meeting of the EASD
Publicado: (2013)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
por: Chairat, Kalayanee, et al.
Publicado: (2016)

1157. Determining the Clinical Utility of 16S rRNA in the Management of Pediatric Infections
por: Lim, Peter Paul, et al.
Publicado: (2021)

224. Effect of Easing Overnight Restrictions on Antimicrobial Starts
por: Yarrington, Michael E, et al.
Publicado: (2020)

53. Effect of rapid identification of bloodstream isolates on antibiotic management using a pharmacist-based treatment algorithm
por: Marshall, Marybeth, et al.
Publicado: (2020)

479. Mobility Restrictions and COVID-19 Pandemic Outbreak Control
por: Starling, Carlos Ernesto Ferreira, et al.
Publicado: (2020)

Chemical Analysis and Transplacental Transfer of Oseltamivir and Oseltamivir Carboxylic Acid in Pregnant Rats
por: Lin, Chia-Chun, et al.
Publicado: (2012)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
por: Vo, Daniel, et al.
Publicado: (2020)

P49 The Barbara Ansell National Network for Adolescent Rheumatology – 10 years on
por: Yorke, Sarah, et al.
Publicado: (2022)

Visitor Restriction Policies and Practices in Children’s Hospitals: Results of an Emerging Infections Network Survey
por: Pong, Alice, et al.
Publicado: (2017)

2644. Evaluation of Clinical Course and Heath-Related Quality-of-Life Following Treatment with Oseltamivir, Laninamivir, and Baloxavir Marboxil in Adult Patients with Seasonal Influenza: Prospective Observational Study
por: Yoshino, Yusuke, et al.
Publicado: (2019)

492. Canadian consensus of COVID-19 policy and management aspects
por: Tsang, Kara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_itsdt8lr83otvfqto5enk41imi